Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EFAVIRENZ for Hiv infection who clinical stage iii: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 35 adverse event reports in the FDA FAERS database where EFAVIRENZ was used for Hiv infection who clinical stage iii.

Most Reported Side Effects for EFAVIRENZ

Side Effect Reports % Deaths Hosp.
Virologic failure 916 11.6% 20 30
Foetal exposure during pregnancy 701 8.9% 137 83
Drug resistance 654 8.3% 15 40
Drug interaction 645 8.2% 146 133
Viral mutation identified 641 8.1% 5 10
Depression 602 7.6% 141 149
Pathogen resistance 567 7.2% 0 31
Maternal exposure during pregnancy 478 6.1% 31 70
Treatment failure 390 4.9% 38 17
Immune reconstitution inflammatory syndrome 301 3.8% 47 148
Death 295 3.7% 295 41
Exposure during pregnancy 251 3.2% 26 39
Treatment noncompliance 222 2.8% 13 47
Abortion spontaneous 221 2.8% 39 44
Lipodystrophy acquired 203 2.6% 1 19

Other Indications for EFAVIRENZ

Hiv infection (5,261) Product used for unknown indication (1,314) Antiretroviral therapy (580) Acquired immunodeficiency syndrome (191) Hiv test positive (64) Hepatitis c (45) Perinatal hiv infection (41) Prophylaxis against hiv infection (40) Maternal exposure timing unspecified (33) Hiv infection cdc category c (31)

Other Drugs Used for Hiv infection who clinical stage iii

LAMIVUDINE (52) NEVIRAPINE (32) EMTRICITABINE (28) ZIDOVUDINE (27) TENOFOVIR (25) STAVUDINE (21) ABACAVIR (16) RITONAVIR (10) DIDANOSINE (9) LOPINAVIR (9)

Related Pages

EFAVIRENZ Full Profile All Hiv infection who clinical stage iii Drugs EFAVIRENZ Demographics EFAVIRENZ Timeline